China Establishes Management Plan For Medical Quality Control Centers
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Health recently issued a pilot edition of management methods for medical care quality control centers to guide health administration departments. The document specifies that the quality control centers are designated by MOH or health administrations of provinces, autonomous regions, municipalities and Xinjiang Production and Construction Corps. These facilities are responsible for the quality control and management of relevant specialist organizations. At the beginning of each year, provincial health administrations should submit their previous year's work report of medical care quality control centers to the national center. The latter will collate, summarize and conduct statistical analysis of the data and publish the information after obtaining MOH approval. (Click here for more - Chinese Language)
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.